InspireMD, Inc.·4

May 8, 5:05 PM ET

Stuka Paul 4

Research Summary

AI-generated summary

Updated

InspireMD (NSPR) Director Paul Stuka Buys 7,895 Shares

What Happened Paul Stuka, a director of InspireMD, acquired a total of 7,895 shares in two open-market purchases: 1,517 shares on 2026-05-06 at $1.12 per share (cost $1,699) and 6,378 shares on 2026-05-07 at an average price of $1.15 per share (cost $7,335). The combined outlay was $9,034. These were purchases (transaction code P), which investors often view as a more positive signal than sales, though filings do not state motivation.

Key Details

  • Transaction dates and prices:
    • 2026-05-06: 1,517 shares @ $1.12 ($1,699)
    • 2026-05-07: 6,378 shares @ $1.15 (weighted average) ($7,335)
  • Total shares acquired: 7,895; total value: $9,034.
  • Shares owned after the transactions: Not specified in the filing.
  • Footnote: The $1.15 price is a weighted average; the May 7 block was purchased in multiple trades at prices ranging from $1.14 to $1.15. The reporting person can provide a breakdown on request.
  • Remarks/Exhibits: Exhibit 24.1 (Power of Attorney) attached.
  • Filing timeliness: Form 4 was filed on 2026-05-08 covering trades on May 6–7; this appears timely under the two-business-day reporting rule.

Context

  • Code P indicates a direct purchase of shares. Purchases by insiders can be interpreted as a vote of confidence, but the monetary size here (~$9k) is modest; small buys can be routine and may not indicate a major change in outlook.
  • The filing does not indicate 10% owner status or the use of a 10b5-1 plan.